@article{47ab51c18f4c440580c5f8960f714141,
title = "Barriers and Facilitators to Oral PrEP Use Among Transgender Women in New York City",
abstract = "Transgender women may face a disparate risk for HIV/AIDS compared to other groups. In 2012, Truvada was approved for daily use as HIV pre-exposure prophylaxis (PrEP). However, there is a dearth of research about barriers and facilitators to PrEP in transgender women. This paper will shed light on transgender women living in New York City{\textquoteright}s perceived and actual challenges to using PrEP and potential strategies to overcome them. After completing an initial screening process, four 90-min focus groups were completed with n = 18 transgender women. Participants were asked what they like and dislike about PrEP. Participants identified the following barriers: uncomfortable side effects, difficulty taking pills, stigma, exclusion of transgender women in advertising, and lack of research on transgender women and PrEP. Facilitators included: reducing pill size, increasing the types of available HIV prevention products, and conducting scientific studies to evaluate PrEP in transgender women.",
keywords = "Barriers, Facilitators, HIV prevention, PrEP, Transgender women, Transwomen",
author = "Rael, {Christine Tagliaferri} and Michelle Martinez and Rebecca Giguere and Walter Bockting and Caitlin MacCrate and Will Mellman and Pablo Valente and Greene, {George J.} and Susan Sherman and Footer, {Katherine H.A.} and D{\textquoteright}Aquila, {Richard T.} and Alex Carballo-Di{\'e}guez",
note = "Funding Information: Funding Data collection support was provided by Project AFFIRM (R01 HD079603; Principle Investigator, Walter Bockting, Ph.D.) and a generous grant from the Mac AIDS Fund (MAF CU13-3233). The first author is supported by a training grant (T32 MH019139; Principle Investigator, Theodorus Sandfort, Ph.D.) from the National Institute of Mental Health at the HIV Center for Clinical and Behavioral Studies at the NY State Psychiatric Institute and Columbia University (P30 MH43520; Center Principle Investigator: Robert Remien, Ph.D.). Additionally, research was supported by SLAP-HIV (UM1 AI120184; Principle Investigator, Tomas Hope, Ph.D.) and the Third Coast Center for AIDS Research (P30 AI117943; Principle Investigator, Richard D{\textquoteright}Aquila, M.D.). Publisher Copyright: {\textcopyright} 2018, Springer Science+Business Media, LLC, part of Springer Nature. Copyright: Copyright 2018 Elsevier B.V., All rights reserved.",
year = "2018",
month = nov,
day = "1",
doi = "10.1007/s10461-018-2102-9",
language = "English (US)",
volume = "22",
pages = "3627--3636",
journal = "AIDS and Behavior",
issn = "1090-7165",
publisher = "Springer New York",
number = "11",
}